Posted in | News | Nanoenergy

Altairnano Receives Purchase Order from Proterra

Altair Nanotechnologies, Inc. (Altairnano) (NASDAQ: ALTI) today announced it has signed a long-term supply agreement with Proterra Inc. to supply advanced lithium-ion battery modules for incorporation into Proterra's all-electric and hybrid-electric buses.

Altairnano's technology enables these buses to completely recharge in under 10 minutes, providing high levels of uptime and efficiency. Combined with industry-leading cycle life, these batteries are ideally suited for the challenging operating conditions experienced by commercial transit buses.

The initial purchase order of $4.6 million is for delivery of modules through June 2011 with ongoing orders anticipated thereafter as Proterra continues to gain customer traction and completes its state-of-the-art manufacturing facility in Greenville, SC. This is a follow-on order to the two earlier orders announced in August 2009 and April 2010.

"This purchase and supply agreement represents a significant milestone and illustrates the growth opportunities present within the mass transit market," said Terry Copeland, President and Chief Executive officer of Altairnano. "This transaction marks the culmination of more than two years of collaboration with Proterra," continued Copeland. "The conclusion of Proterra's research was that Altairnano's advanced lithium-ion battery modules are a perfect fit for Proterra's transit bus application. We look forward to working together to bring these new electric buses to market and delivering on the promise of more cost effective and sustainable transportation solutions."

Under the terms of this new agreement Altairnano will supply advanced battery modules for use in Proterra's electric and hybrid-electric buses being marketed to municipalities and transportation authorities throughout the Americas and Europe. The two companies will work closely together to drive down the overall costs of the end product to the customer and add near-term credibility to the promise of a greener, more energy independent nation in the mass-transit arena.

"About a year-and-half ago we focused the company on mass transit and stationary power applications. We have been steadily building our sales pipeline over the past year and a number of those opportunities are now coming to fruition," continued Dr. Copeland. "We are continuing to commercialize our battery technology for the stationary power, transportation and defense markets in challenging operating environments where safety, performance and long-life are valued."

"Incorporating Altair's battery technology is a key enabler for Proterra to achieve its mission to deliver the only viable low-cost, zero emission battery electric transit buses that are a viable one-for-one replacement for conventional diesel buses," said Jeff Granato, Chief Executive Officer of Proterra. "Proterra's products have never been more relevant given our current global environmental and economic circumstances to decrease dependence on foreign oil and significantly reduce transit agency operating costs."

Source: http://www.altairnano.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Altair Nanotechnologies. (2019, March 19). Altairnano Receives Purchase Order from Proterra. AZoNano. Retrieved on June 18, 2024 from https://www.azonano.com/news.aspx?newsID=18240.

  • MLA

    Altair Nanotechnologies. "Altairnano Receives Purchase Order from Proterra". AZoNano. 18 June 2024. <https://www.azonano.com/news.aspx?newsID=18240>.

  • Chicago

    Altair Nanotechnologies. "Altairnano Receives Purchase Order from Proterra". AZoNano. https://www.azonano.com/news.aspx?newsID=18240. (accessed June 18, 2024).

  • Harvard

    Altair Nanotechnologies. 2019. Altairnano Receives Purchase Order from Proterra. AZoNano, viewed 18 June 2024, https://www.azonano.com/news.aspx?newsID=18240.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.